Loading…
CARBOGEN AMCIS will build a new facility in Riom, France for custom development and manufacturing of parenteral drug products. Construction begins January 2021.
CARBOGEN AMCIS announces two expansion projects: a new API manufacturing facility in Hunzenschwil, Switzerland (operational by summer 2024) and a new parenteral drug product facility in Riom, France (construction starts January 2021). Total investment exceeds CHF 100 million.
| Site | Largest | Latest |
|---|---|---|
| Hunzenschwil, Switzerland | $108.0M | 2020-08-17 |
| Riom, France | 2020-08-17 |